Metagenomics study on taxonomic and functional change of gut microbiota in patients with obesity with PCOS treated with exenatide combination with metformin or metformin alone

References

• Giampaolino P, Foreste V, Di Filippo C, et al. Microbiome and PCOS: state-of-Art and future aspects. Int J Mol Sci. 2021;22(4):1.
   Web of Science ®Google Scholar
• Escobar-Morreale H. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270–9.
   PubMed Web of Science ®Google Scholar
• Hoeger KM, Dokras A, Piltonen T. Update on PCOS: consequences, challenges, and guiding treatment. J Clin Endocrinol Metab. 2021;106(3):e1071–e1083.
   PubMed Web of Science ®Google Scholar
• Siamashvili M, Davis S. Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndrome. Expert Rev Clin Pharmacol. 2021;14(9):1081–1089.
   PubMed Web of Science ®Google Scholar
• Morley LC, Tang T, Yasmin E, et al. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. 2017;11(11):CD003053.
   PubMedGoogle Scholar
• Practice committee of the American society for reproductive medicine. Electronic address: [email protected]; practice committee of the American society for reproductive medicine . Role of metformin for ovulation induction in infertile patients with polycystic ovary syndrome (PCOS): a guideline. Fertil Steril. 2017;108(3):426–441.
   PubMed Web of Science ®Google Scholar
• Garg S. The role of basal insulin and glucagon-like peptide-1 agonists in the therapeutic management of type 2 diabetes–a comprehensive review. Diabetes Technol Ther. 2010;12(1):11–24.
   PubMed Web of Science ®Google Scholar
• Vilsbøll T, Christensen M, Junker AE, et al. Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials. BMJ. 2012;344:d7771.
   PubMed Web of Science ®Google Scholar
• Glintborg D, Mumm H, Holst JJ, et al. Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome. Endocr Connect. 2017;6(4):267–277.
   PubMed Web of Science ®Google Scholar
• Frøssing S, Nylander M, Chabanova E, et al. Effect of liraglutide on ectopic fat in polycystic ovary syndrome: a randomized clinical trial. Diabetes Obes Metab. 2018;20(1):215–218.
   PubMed Web of Science ®Google Scholar
• Pascale A, Marchesi N, Marelli C, et al. Microbiota and metabolic diseases. Endocrine. 2018;61(3):357–371.
   PubMed Web of Science ®Google Scholar
• Rangan KJ, Hang H. Biochemical mechanisms of pathogen restriction by intestinal bacteria. Trends Biochem Sci. 2017;42(11):887–898.
   PubMed Web of Science ®Google Scholar
• Sonnenburg JL, Bäckhed F. Diet-microbiota interactions as moderators of human metabolism. Nature. 2016;535(7610):56–64.
   PubMed Web of Science ®Google Scholar
• Bäckhed F, Roswall J, Peng Y, et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe. 2015;17(5):690–703.
   PubMed Web of Science ®Google Scholar
• Barko PC, McMichael MA, Swanson KS, et al. The gastrointestinal microbiome: a review. J Vet Intern Med. 2018;32(1):9–25.
   PubMed Web of Science ®Google Scholar
• Durack J, Lynch S. The gut microbiome: relationships with disease and opportunities for therapy. J Exp Med. 2019;216(1):20–40.
   PubMed Web of Science ®Google Scholar
• Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. 2016;375(24):2369–2379.
   PubMed Web of Science ®Google Scholar
• Wu D, Wang H, Xie L, et al. Cross-Talk between gut microbiota and adipose tissues in obesity and related metabolic diseases. Front Endocrinol (Lausanne). 2022;13(13):908868.
   PubMedGoogle Scholar
• Chu W, Zhai J, Xu J, et al. Continuous Light-Induced PCOS-Like changes in reproduction, metabolism, and gut microbiota in Sprague-Dawley rats. Front Microbiol. 2019;10(10):3145.
   PubMedGoogle Scholar
• Guney G, Taskin MI, Baykan O, et al. Endotrophin as a novel marker in PCOS and its relation with other adipokines and metabolic parameters: a pilot study. Ther Adv Endocrinol Metab. 2021;12(12):20420188211049607.
   Google Scholar
• Zhou L, Ni Z, Yu J, et al. Correlation between fecal metabolomics and gut microbiota in obesity and polycystic ovary syndrome. Front Endocrinol (Lausanne). 2020;11(11):628.
   PubMedGoogle Scholar
• He F, Li Y. The gut microbial composition in polycystic ovary syndrome with insulin resistance: findings from a normal-weight population. J Ovarian Res. 2021;14(1):50.
   PubMed Web of Science ®Google Scholar
• Zhang J, Sun Z, Jiang S, et al. Probiotic Bifidobacterium lactis V9 regulates the secretion of sex hormones in polycystic ovary syndrome patients through the Gut-Brain axis. mSystems. 2019;4(2):e00017–00019.
   Web of Science ®Google Scholar
• Chu W, Han Q, Xu J, et al. Metagenomic analysis identified microbiome alterations and pathological association between intestinal microbiota and polycystic ovary syndrome. Fertil Steril. 2020;113(6):1286–1298.e4.
   PubMed Web of Science ®Google Scholar
• He F-F, Li Y-M. Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review. J Ovarian Res. 2020;13(1):73.
   PubMed Web of Science ®Google Scholar
• Zhao L, Chen Y, Xia F, et al. A Glucagon-Like peptide-1 receptor agonist lowers weight by modulating the structure of gut microbiota. Front Endocrinol (Lausanne). 2018;9:233.
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–25.
   Web of Science ®Google Scholar
• Han Y, Li Y, He B. GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis. Reprod Biomed Online. 2019;39(2):332–342.
   PubMed Web of Science ®Google Scholar
• Elkind-Hirsch K, Marrioneaux O, Bhushan M, et al. Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2008;93(7):2670–2678.
   PubMed Web of Science ®Google Scholar
• Tao T, Zhang Y, Zhu Y-C, et al. Exenatide, metformin, or both for prediabetes in PCOS: a randomized, open-label, parallel-group controlled study. J Clin Endocrinol Metab. 2021;106(3):e1420–e1432.
   PubMed Web of Science ®Google Scholar
• Thursby E, Juge N. Introduction to the human gut microbiota. Biochem J. 2017;474(11):1823–1836.
   PubMed Web of Science ®Google Scholar
• Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012;489(7415):242–249.
   PubMed Web of Science ®Google Scholar
• Yurtdaş G, Akdevelioğlu Y. A new approach to polycystic ovary syndrome: the gut microbiota. J Am Coll Nutr. 2020;39(4):371–382.
   PubMed Web of Science ®Google Scholar
• Liu R, Zhang C, Shi Y, et al. Dysbiosis of gut microbiota associated with clinical parameters in polycystic ovary syndrome. Front Microbiol. 2017;8:324.
   PubMed Web of Science ®Google Scholar
• Guo J, Shao J, Yang Y, et al. Gut microbiota in patients with polycystic ovary syndrome: a systematic review. Reprod Sci. 2022;29(1):69–83.
   PubMed Web of Science ®Google Scholar
• Kohl KD, Amaya J, Passement CA, et al. Unique and shared responses of the gut microbiota to prolonged fasting: a comparative study across five classes of vertebrate hosts. FEMS Microbiol Ecol. 2014;90(3):883–894.
   PubMed Web of Science ®Google Scholar
• Parker BJ, Wearsch PA, Veloo ACM, et al. The genus alistipes: gut bacteria with emerging implications to inflammation, cancer, and mental health. Front Immunol. 2020;11:906.
   PubMed Web of Science ®Google Scholar
• Jobira B, Frank DN, Pyle L, et al. Obese adolescents with PCOS have altered biodiversity and relative abundance in gastrointestinal microbiota. J Clin Endocrinol Metab. 2020;105(6):e2134–2144–e2144.
   Web of Science ®Google Scholar
• Binda C, Lopetuso LR, Rizzatti G, et al. Actinobacteria: a relevant minority for the maintenance of gut homeostasis. Dig Liver Dis. 2018;50(5):421–428.
   PubMedGoogle Scholar
• Wahida A, Tang F, Barr JJ. Rethinking phage-bacteria-eukaryotic relationships and their influence on human health. Cell Host Microbe. 2021;29(5):681–688.
   PubMed Web of Science ®Google Scholar
• Koopen A, Witjes J, Wortelboer K, et al. Duodenal anaerobutyricum soehngenii infusion stimulates GLP-1 production, ameliorates glycaemic control and beneficially shapes the duodenal transcriptome in metabolic syndrome subjects: a randomised double-blind placebo-controlled cross-over study. Gut Microbes. 2021;25:gutjnl-2020-323297.
   Google Scholar
• Yoshida N, Emoto T, Yamashita T, et al. Bacteroides vulgatus and Bacteroides dorei reduce gut microbial lipopolysaccharide production and inhibit atherosclerosis. Circulation. 2018;138(22):2486–2498.
   PubMed Web of Science ®Google Scholar
• You JS, Yong JH, Kim GH, et al. Commensal-derived metabolites govern Vibrio cholerae pathogenesis in host intestine. Microbiome. 2019;7:132.
   Google Scholar
• Steimle A, Michaelis L, Di Lorenzo F, et al. Weak agonistic LPS restores intestinal immune homeostasis. Mol Ther. 2019;27(11):1974–1991.
   PubMed Web of Science ®Google Scholar
• Wang K, Liao M, Zhou N, et al. Parabacteroides distasonis alleviates obesity and metabolic dysfunctions via production of succinate and secondary bile acids. Cell Rep. 2019;26(1):222–235.e5.
   PubMed Web of Science ®Google Scholar
• He Y, Wang Q, Li X, et al. Lactic acid bacteria alleviate polycystic ovarian syndrome by regulating sex hormone related gut microbiota. Food Funct. 2020;11(6):5192–5204.
   PubMed Web of Science ®Google Scholar
• Huang J, Chen P, Xiang Y, et al. Gut microbiota dysbiosis-derived macrophage pyroptosis causes polycystic ovary syndrome via steroidogenesis disturbance and apoptosis of granulosa cells. Int Immunopharmacol. 2022;107:108717.
   PubMed Web of Science ®Google Scholar
• Zhai Q, Feng S, Arjan N, et al. A next generation probiotic, Akkermansia muciniphila. Crit Rev Food Sci Nutr. 2019;59(19):3227–3236.
   PubMed Web of Science ®Google Scholar
• Tan H, Zhai Q, Chen W. Investigations of bacteroides spp. towards next-generation probiotics. Food Res Int. 2019;116:637–644.
   PubMed Web of Science ®Google Scholar
• Ha CWY, Martin A, Sepich-Poore GD, et al. Translocation of viable gut microbiota to mesenteric adipose drives formation of creeping fat in humans. Cell. 2020;183(3):666–683.e17.
   PubMed Web of Science ®Google Scholar
• Cherny KE, Ozer EA, Kochan TJ, et al. Complete genome sequence of Clostridium innocuum strain LC-LUMC-CI-001, isolated from a patient with recurrent antibiotic-associated diarrhea. Microbiol Resour Announc. 2020;9(28):e00365-00320.
   Web of Science ®Google Scholar
• Lakhdari O, Tap J, Béguet-Crespel F, et al. Identification of NF-κB modulation capabilities within human intestinal commensal bacteria. J Biomed Biotechnol. 2011;2011:282356.
   PubMedGoogle Scholar
• Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol. 2017;19(1):29–41.
   PubMed Web of Science ®Google Scholar
• Prakash S, Rodes L, Coussa-Charley M, et al. Gut microbiota: next frontier in understanding human health and development of biotherapeutics. Biologics. 2011;5:71–86.
   PubMedGoogle Scholar
• Ait Chait Y, Gunenc A, Hosseinian F, et al. Antipathogenic and probiotic potential of Lactobacillus brevis strains newly isolated from Algerian artisanal cheeses. Folia Microbiol (Praha). 2021;66(3):429–440.
   PubMed Web of Science ®Google Scholar
• Song MW, Chung Y, Kim KT, et al. Probiotic characteristics of Lactobacillus brevis B13–2 isolated from kimchi and investigation of antioxidant and immune-modulating abilities of its heat-killed cells. LWT. 2020;128:109452.
   Web of Science ®Google Scholar
• Pourbaferani M, Modiri S, Norouzy A, et al. A newly characterized potentially probiotic strain, Lactobacillus brevis MK05, and the toxicity effects of its secretory proteins against MCF-7 breast cancer cells. Probiotics Antimicrob Proteins. 2021;13(4):982–992.
   PubMed Web of Science ®Google Scholar
• Li L, Yang B, Humza M, et al. A novel strain Lactobacillus brevis 8–2B inhibiting Aspergillus carbonarius growth and ochratoxin a production. LWT. 2021;136:110308.
   Web of Science ®Google Scholar
• Defois C, Ratel J, Garrait G, et al. Food chemicals disrupt human gut microbiota activity and impact intestinal homeostasis as revealed by in vitro systems. Sci Rep. 2018;8(1):11006.
   PubMedGoogle Scholar
• Maqdasy S, Lecoutre S, Renzi G, et al. Impaired phosphocreatine metabolism in white adipocytes promotes inflammation. Nat Metab. 2022;4(2):190–202.
   PubMedGoogle Scholar